Caroline Loew, Ph.D.: Building an Innovative Biotech

Caroline Loew, Ph.D.  is the President and CEO of Glympse Bio, an MIT spin out company trying to change the paradigm of in vivo diagnostic and prognostic monitoring for a wide range of disease indications. Prior to running Glympse Bio, Caroline held a number of high-level positions within some of the top global pharmaceutical companies including Merck and most recently Bristol Myers-Squibb. Her roles spanned a number of business units related to market access, commercialization, strategy, and planning. Dr. Loew earned a Ph.D. in organic chemistry from Imperial College London.In this episode, Caroline shares her insights learned from a fruitful career in biotech and pharma. She highlights the idea of building the base of your career following your Ph.D.. Additionally, Caroline discusses the founding and development of Glympse Bio- and shares some of the key areas of development for the company and their technology over the next 5 years.Hosted by Joe Varriale.